• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析肺部非结核分枝杆菌病中的分枝杆菌群落。

Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease.

机构信息

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Host Defence Unit, Royal Brompton Hospital, London, United Kingdom.

出版信息

PLoS One. 2018 Dec 11;13(12):e0208018. doi: 10.1371/journal.pone.0208018. eCollection 2018.

DOI:10.1371/journal.pone.0208018
PMID:30533049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6289444/
Abstract

The diagnosis of pulmonary non-tuberculous mycobacterial disease (pNTM) is dependent on the isolation of NTM in culture, which is prone to overgrowth and contamination and may not capture the diversity of mycobacteria present, including rare or unidentified species. This study aimed to develop a culture independent method of detecting and identifying mycobacteria from sputum samples using partial sequencing of the hsp65 gene. DNA was extracted from sputum samples from subjects with pNTM and disease controls. Multiplexed partial sequencing of the hsp65 gene was performed using the Illumina MiSeq and custom primers. A reference database of hsp65 sequences was created for taxonomy assignment. Sequencing results were obtained from 42 subjects (31 cases, 11 controls). Mycobacterial sequences were identified in all subjects. In 90.5% of samples more than one species was found (median 5.5). The species isolated in culture was detected by sequencing in 81% of subjects and was the most abundant species in 62%. The sequencing of NTM from clinical samples reveals a far greater diversity than conventional culture and suggests NTM are present as communities rather than a single species. NTM were found to be present even in the absence of isolation in culture or clinical disease.

摘要

肺部非结核分枝杆菌病(pNTM)的诊断依赖于分枝杆菌的培养分离,而培养容易出现过度生长和污染,并且可能无法捕捉到存在的分枝杆菌的多样性,包括罕见或未鉴定的物种。本研究旨在开发一种使用 hsp65 基因部分测序从痰样本中检测和鉴定分枝杆菌的非培养依赖方法。从 pNTM 患者和疾病对照者的痰样本中提取 DNA。使用 Illumina MiSeq 和定制引物对 hsp65 基因进行多重部分测序。创建了 hsp65 序列的参考数据库以进行分类学分配。从 42 名受试者(31 例,11 例对照)中获得了测序结果。在所有受试者中均鉴定出分枝杆菌序列。在 90.5%的样本中发现了一种以上的物种(中位数为 5.5)。在 81%的受试者中通过测序检测到培养分离的物种,在 62%的受试者中该物种是最丰富的。从临床样本中对 NTM 的测序揭示了比传统培养更广泛的多样性,并表明 NTM 以群落而不是单一物种存在。即使在培养分离或临床疾病不存在的情况下也发现存在 NTM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b5/6289444/96e9dc6627d9/pone.0208018.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b5/6289444/96e9dc6627d9/pone.0208018.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b5/6289444/96e9dc6627d9/pone.0208018.g001.jpg

相似文献

1
Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease.分析肺部非结核分枝杆菌病中的分枝杆菌群落。
PLoS One. 2018 Dec 11;13(12):e0208018. doi: 10.1371/journal.pone.0208018. eCollection 2018.
2
Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002-2016.2002-2016 年,从突尼斯北部肺结核疑似患者标本中分离出的非结核分枝杆菌。
BMC Infect Dis. 2019 Sep 18;19(1):819. doi: 10.1186/s12879-019-4441-1.
3
[Distribution of nontuberculous mycobacteria isolated from clinical specimens and identified with DNA sequence analysis].[从临床标本中分离并经DNA序列分析鉴定的非结核分枝杆菌的分布]
Mikrobiyol Bul. 2015 Oct;49(4):484-93. doi: 10.5578/mb.9698.
4
Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens.痰标本中单一致病菌非结核分枝杆菌的分离的临床意义。
Diagn Microbiol Infect Dis. 2013 Feb;75(2):225-6. doi: 10.1016/j.diagmicrobio.2012.09.021. Epub 2012 Nov 7.
5
Restriction enzyme analysis of the hsp65 gene in clinical isolates from patients suspected of having pulmonary tuberculosis in Teresina, Brazil.巴西特雷斯皮纳疑似肺结核患者临床分离株 hsp65 基因的限制性酶切分析。
J Bras Pneumol. 2011 Sep-Oct;37(5):628-35. doi: 10.1590/s1806-37132011000500010.
6
Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment.稳定非结核分枝杆菌肺病患者与需要治疗患者的痰微生物组比较。
BMC Microbiol. 2024 May 18;24(1):172. doi: 10.1186/s12866-024-03308-2.
7
Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的微生物学诊断。
Clin Chest Med. 2015 Mar;36(1):43-54. doi: 10.1016/j.ccm.2014.11.005. Epub 2014 Dec 18.
8
Molecular identification and distribution of non-tuberculous mycobacteria isolated from clinical specimens by PCR-sequencing method in West of Iran.伊朗西部采用PCR测序法从临床标本中分离出的非结核分枝杆菌的分子鉴定与分布
Clin Respir J. 2018 Mar;12(3):996-1002. doi: 10.1111/crj.12617. Epub 2017 Mar 9.
9
Identification of Species of Nontuberculous Mycobacteria Clinical Isolates from 8 Provinces of China.中国8个省份临床分离的非结核分枝杆菌菌种鉴定
Biomed Res Int. 2016;2016:2153910. doi: 10.1155/2016/2153910. Epub 2016 Nov 2.
10
Diagnosis of Nontuberculous Mycobacteria Lung Disease.非结核分枝杆菌肺病的诊断。
Semin Respir Crit Care Med. 2018 Jun;39(3):343-350. doi: 10.1055/s-0038-1651493. Epub 2018 Aug 2.

引用本文的文献

1
Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者痰液微生物群基于治愈状态的差异。
Korean J Intern Med. 2025 May;40(3):449-457. doi: 10.3904/kjim.2024.209. Epub 2025 Mar 25.
2
Evidence of DNA in shared water sources at livestock-wildlife-human interfaces in KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省家畜 - 野生动物 - 人类界面共享水源中DNA的证据。
Front Vet Sci. 2025 Feb 28;12:1483162. doi: 10.3389/fvets.2025.1483162. eCollection 2025.
3
Non-Tuberculous Mycobacteria: Single Center Analyses of Risk Factors, Management and Mortality Outcomes of Adults with HIV.

本文引用的文献

1
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.稳定期慢性阻塞性肺疾病、吸烟者和健康非吸烟者的社区动态与下呼吸道微生物群。
Thorax. 2016 Sep;71(9):795-803. doi: 10.1136/thoraxjnl-2015-207235. Epub 2016 May 4.
2
Update on pulmonary disease due to non-tuberculous mycobacteria.非结核分枝杆菌所致肺部疾病的最新进展。
Int J Infect Dis. 2016 Apr;45:123-34. doi: 10.1016/j.ijid.2016.03.006. Epub 2016 Mar 11.
3
The antimicrobial susceptibility of non-tuberculous mycobacteria.
非结核分枝杆菌:成人HIV感染者危险因素、管理及死亡率结局的单中心分析
Diagnostics (Basel). 2024 Nov 27;14(23):2682. doi: 10.3390/diagnostics14232682.
4
Nontuberculous Mycobacteria, Mucociliary Clearance, and Bronchiectasis.非结核分枝杆菌、黏液纤毛清除功能与支气管扩张症
Microorganisms. 2024 Mar 27;12(4):665. doi: 10.3390/microorganisms12040665.
5
Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management.非结核分枝杆菌肺病(NTM-PD):流行病学、诊断和多学科管理。
Clin Med (Lond). 2024 Jan;24(1):100017. doi: 10.1016/j.clinme.2024.100017. Epub 2024 Jan 17.
6
The lung microbiota in nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病中的肺部微生物组。
PLoS One. 2023 May 26;18(5):e0285143. doi: 10.1371/journal.pone.0285143. eCollection 2023.
7
Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease.非结核分枝杆菌病治疗中分枝杆菌负荷的分子评估
ERJ Open Res. 2023 Mar 20;9(2). doi: 10.1183/23120541.00435-2022. eCollection 2023 Mar.
8
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease.结核病和非结核分枝杆菌肺病的个性化医疗
Microorganisms. 2021 Oct 26;9(11):2220. doi: 10.3390/microorganisms9112220.
9
The Lung Microbiome during Health and Disease.肺部微生物组在健康和疾病中的作用
Int J Mol Sci. 2021 Oct 8;22(19):10872. doi: 10.3390/ijms221910872.
10
Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, and Immunosenescence.免疫衰退期的温热加糖牛奶——阿尔茨海默病——炎症衰老、胰岛素抵抗和免疫衰老
Front Immunol. 2021 Aug 5;12:714179. doi: 10.3389/fimmu.2021.714179. eCollection 2021.
非结核分枝杆菌的抗菌药物敏感性。
J Infect. 2016 Mar;72(3):324-31. doi: 10.1016/j.jinf.2015.12.007. Epub 2015 Dec 24.
4
Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.尿液核酸扩增试验对肺结核的诊断准确性:一项荟萃分析。
Int J Tuberc Lung Dis. 2015 Nov;19(11):1339-47. doi: 10.5588/ijtld.15.0209.
5
The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.美国非结核分枝杆菌肺病的负担
Ann Am Thorac Soc. 2015 Oct;12(10):1458-64. doi: 10.1513/AnnalsATS.201503-173OC.
6
Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data.通过对 Illumina MiSeq 数据进行测序后处理,从细菌含量低的人体样本中获取准确的微生物组图谱。
Microbiome. 2015 May 5;3:19. doi: 10.1186/s40168-015-0083-8. eCollection 2015.
7
Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.快速检测与囊性纤维化严重肺部疾病相关的新出现病原体及微生物多样性丧失
J Clin Microbiol. 2015 Jul;53(7):2022-9. doi: 10.1128/JCM.00432-15. Epub 2015 Apr 15.
8
The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract.人类健康口腔和上呼吸道中的隐藏“分枝杆菌组”。
J Oral Microbiol. 2015 Feb 13;7:26094. doi: 10.3402/jom.v7.26094. eCollection 2015.
9
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.试剂和实验室污染会严重影响基于序列的微生物组分析。
BMC Biol. 2014 Nov 12;12:87. doi: 10.1186/s12915-014-0087-z.
10
The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy.鸟分枝杆菌复合群肺病治疗期间脓肿分枝杆菌脓肿亚种分离的意义。
Chest. 2015 May;147(5):1369-1375. doi: 10.1378/chest.14-1297.